‘Europe's cannabis sector is at a pivotal inflection point, but we are in desperate need of large-scale clinical programs to build the high-quality evidence b…’
Speaking on Cannabis and Women
Dr Grace Blest-Hopley is a neuroscientist, Research Associate at King's College London, and Chief Scientific Officer at NW PhamaTech, where she leads clinical trials focused on psychosis prevention. She is also the founder of Hystelica - a platform advancing women's health education at the intersection of cannabis, psychedelics, and hormonal biology.
Holding a PhD in Neuroscience, Grace is a leading voice on sex-specific pharmacology and the underrepresentation of women in clinical research. Her work explores how the endocannabinoid system interacts with female biology across the menstrual cycle and hormonal milestones, translating complex science into accessible education for clinicians and patients alike.
Published in the field of sex-specific considerations in cannabinoid and psychedelic medicine, Grace bridges the gap between bench science and real-world clinical application. A passionate advocate for bringing women's voices into cannabis science and policy, she is committed to ensuring the next generation of cannabis medicine is built with - not just for - women
On the London 2026 programme
- Day 2 · Main Stage · 11:30 amCan Cannabis Help to Close the Gender Health Gap? From Stigma to Solutions in Women's Health